Image may be NSFW.
Clik here to view.
Clik here to view.
William Blair starts Vital Therapies at outperform
William Blair has initiated coverage of Vital Therapies (NASDAQ:VTL) with an “outperform” rating and a $28 price target. The stock closed at $12.34 on Friday. Analyst Katherine Xu writes that the...
View Article
Image may be NSFW.
Clik here to view.
Clik here to view.
WB ups Vital Therapies price target to $36
William Blair has raised its price target on “outperform-rated” Vital Therapies (NASDAQ:VTL) to $36 from $28, citing an update on the status of the ELAD clinical program and highlights from investor...
View Article
Image may be NSFW.
Clik here to view.
Clik here to view.
Vital Therapies prices follow-on offering
Vital Therapies (NASDAQ:VTL) has priced a follow-on public offering of two million common shares at a price of $17.50 each and granted underwriters a 30-day option to purchase up to an additional...
View Article
More Pages to Explore .....
